Literature DB >> 16815628

Prostate cancer susceptibility is mediated by interactions between exposure to ultraviolet radiation and polymorphisms in the 5' haplotype block of the vitamin D receptor gene.

Nicholas J Rukin1, Christopher Luscombe, Sam Moon, Dhaval Bodiwala, Samson Liu, Mark F Saxby, Anthony A Fryer, Julie Alldersea, Paul R Hoban, Richard C Strange.   

Abstract

Vitamin D receptor (VDR) polymorphisms are prostate cancer risk candidates. We determined if SNPs in haplotype block sub-regions C2 (SNPs C2-1, G/C(3436), C2-2, A/G(3944)) or C1 (C1-1, C/T(20965), C1-2, C/T(30056)) are associated with risk in an ultraviolet radiation (UVR)-dependent manner. In men with very low exposure, SNPs in both sub-regions were associated with risk. Various haplotypes in haplotype block C including G(3436)-A(3944)-C(20965)-C(30056), (G or C)-A-C-C and G-A-(C or T)-C were significantly associated with increased risk (odds ratios between 1.95 and 2.37). These findings suggest various block C SNPs are associated with prostate cancer risk via a mechanism involving exposure to sunlight.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815628     DOI: 10.1016/j.canlet.2006.05.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Lack of association between vitamin D receptor gene FokI and BsmI polymorphisms and prostate cancer risk: an updated meta-analysis involving 21,756 subjects.

Authors:  Zhan Guo; Jianguo Wen; Quancheng Kan; Shuman Huang; Xianghua Liu; Ning Sun; Zhenzhen Li
Journal:  Tumour Biol       Date:  2013-06-27

2.  Vitamin D pathway gene variants and prostate cancer prognosis.

Authors:  Sarah K Holt; Erika M Kwon; Joseph S Koopmeiners; Daniel W Lin; Ziding Feng; Elaine A Ostrander; Ulrike Peters; Janet L Stanford
Journal:  Prostate       Date:  2010-09-15       Impact factor: 4.104

3.  Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2011-07-01

4.  Polymorphisms in the vitamin D Receptor (VDR) and the risk of ovarian cancer: a meta-analysis.

Authors:  Yanling Liu; Chenglin Li; Peizhan Chen; Xiaoguang Li; Mian Li; He Guo; Jingquan Li; Ruiai Chu; Hui Wang
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

5.  Vitamin d, sunlight and prostate cancer risk.

Authors:  Krishna Vanaja Donkena; Charles Y F Young
Journal:  Adv Prev Med       Date:  2011-06-08

6.  Evidence of differential effects of vitamin d receptor variants on epithelial ovarian cancer risk by predicted vitamin d status.

Authors:  Jennifer Prescott; Kimberly A Bertrand; Brett M Reid; Jennifer Permuth-Wey; Immaculata De Vivo; Daniel W Cramer; Kathryn L Terry; Shelley S Tworoger
Journal:  Front Oncol       Date:  2014-10-20       Impact factor: 5.738

7.  Updated analysis of vitamin D receptor gene FokI polymorphism and prostate cancer susceptibility.

Authors:  Yuan-Yuan Mi; Yang-Zhi Chen; Jing Chen; Li-Feng Zhang; Li Zuo; Jian-Gang Zou
Journal:  Arch Med Sci       Date:  2016-08-16       Impact factor: 3.318

8.  Association of Vitamin D receptor Fok I polymorphism with the risk of prostate cancer: a meta-analysis.

Authors:  Shaosan Kang; Yansheng Zhao; Jian Liu; Lei Wang; Geng Zhao; Xi Chen; Anliang Yao; Liguo Zhang; Xiaojun Zhang; Xiaoqiang Li
Journal:  Oncotarget       Date:  2016-11-22

9.  Vitamin d pathway genes, diet, and risk of renal cell carcinoma.

Authors:  S Karami; P Brennan; M Navratilova; D Mates; D Zaridze; V Janout; H Kollarova; V Bencko; V Matveev; N Szesznia-Dabrowska; I Holcatova; M Yeager; S Chanock; N Rothman; P Boffetta; W-H Chow; L E Moore
Journal:  Int J Endocrinol       Date:  2009-11-05       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.